Latest pulmonary fibrosis Stories
BURLINGTON, ON, Jan. 17, 2013 /CNW/ - When diagnosed with idiopathic pulmonary fibrosis (IPF), a progressive, debilitating and ultimately fatal disease of the lungs, patients have had minimal treatment options - until today. Following Health Canada's market approval of Esbriet(TM) (pirfenidone) ["Esbriet"] on October 1, 2012, InterMune Canada Inc. has announced that the only treatment indicated for mild to moderate IPF in adults is now available in Canada. "Prior to the...
Groups provide support for Pulmonary Fibrosis patients, caregivers, families CULVER CITY, Calif., Jan. 15, 2013 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today its partnership with Breathe Support to provide online support groups for Pulmonary Fibrosis (PF) patients, families and caregivers. Breathe Support provides online forums for PF patients, caregivers and families and those dealing with the grief of their loss. There are separate groups...
Supports Patients and Efforts for Cure for Deadly Lung Disease CULVER CITY, Calif., Dec. 27, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today its accomplishments for the year, reflecting on the successes in Pulmonary Fibrosis (PF) research, advocacy and awareness efforts. "We are pleased to say that 2012 was a good year for the foundation and for our patients as we inch closer to treatments and a cure," said Mishka Michon, Chief Executive...
Actress Leads Awareness Activities for Coalition for Pulmonary Fibrosis' Daughters of PF program HOLLYWOOD, Calif., Dec. 12, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis announced today motion picture and television actress Rose McGowan will be a guest on Friday, December 14(th) on CBS TV's The Doctors. She will share her tragic personal story of how she watched her father suffer and die from the incurable lung disease, Pulmonary Fibrosis (PF) and help raise...
CPF Joins Doctors to Identify Needs, Gaps and Challenges in Pulmonary Fibrosis Research BETHESDA, Md., Nov. 30, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) participated in a landmark meeting at the National Institutes of Health (NIH)'s National Heart, Lung, and Blood Institute (NHLBI) this week that promises to pave the path forward to finding answers to the deadly lung disease, Pulmonary Fibrosis (PF). The Idiopathic Pulmonary Fibrosis Strategic...
"Westie" Dogs May Hold Answers to Pulmonary Fibrosis, Disease that Claims as Many Lives as Breast Cancer CULVER CITY, Calif., Nov. 14, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) and The Westie Foundation of America (WFA) announced today a strategic alliance to fight a deadly lung disease that claims as many human lives as breast cancer each year and a similar percentage of West Highland Terriers, it is believed, as well. The CPF is a human...
SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Genoa Pharmaceuticals, a biotechnology company developing novel therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF), announced today the completion of a $1.2M financing. Funds from the financing will be used to advance its lead program, GP-101 (aerosol pirfenidone). IPF is a fatal lung disease caused by both genetic and environmental factors resulting in progressive lung scarring and characterized by reduced exercise capacity...
Agencies Request input from Patients, Families CULVER CITY, Calif., Oct. 31, 2012 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) spoke out for the more than 128,000 people suffering from Pulmonary Fibrosis (PF) and their families at recent forums that asked for patient comment on efforts related to drug development and research. The efforts were with the Food and Drug Administration's (FDA) new congressionally mandated Patient-Focused Drug Development...
Foundation Recognizes 2012 Investigator Award Recipients at Annual Dinner CHICAGO, Oct. 23, 2012 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it is accepting letters of intent for its 2012 PFF Research Fund grants. Letters of intent will be accepted until Monday, November 26, 2012. One of the primary goals of the PFF Research Fund is to support research that will ultimately lead to successful therapies for pulmonary fibrosis (PF). As...
Breathe Benefit 2012 Honors Co-Founder and Acknowledges Grant Recipients CHICAGO, Oct. 17, 2012 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation's (PFF) annual dinner, Breathe Benefit 2012: Community Inspiring a Cure, was held on Saturday, October 13, 2012, and raised over $150,000. The money will be used to support the goals of the Foundation's mission which include finding a cure for idiopathic pulmonary fibrosis (IPF), advocating for the pulmonary fibrosis (PF)...
